Related Experiment Video

Updated: Jul 7, 2026

In vivo Dual Substrate Bioluminescent Imaging
07:33

In vivo Dual Substrate Bioluminescent Imaging

Published on: October 11, 2011

In-vivo skills and UK competitiveness in biomedical sciences

Clive Page1

  • 1Sackler Institute of Pulmonary Pharmacology, Division of Pharmaceutical Sciences, King's College London, London SE1 1UL, UK. clive.page@kcl.ac.uk

Lancet (London, England)
|March 4, 2008
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Expanding the Toolkit for In Vivo Imaging of Axonal Transport
09:24

Expanding the Toolkit for In Vivo Imaging of Axonal Transport

Published on: December 23, 2021

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

Related Experiment Videos

Last Updated: Jul 7, 2026

In vivo Dual Substrate Bioluminescent Imaging
07:33

In vivo Dual Substrate Bioluminescent Imaging

Published on: October 11, 2011

Expanding the Toolkit for In Vivo Imaging of Axonal Transport
09:24

Expanding the Toolkit for In Vivo Imaging of Axonal Transport

Published on: December 23, 2021

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

Related Concept Videos

Equivalence: In Vitro and In Vivo Bioequivalence01:17

Equivalence: In Vitro and In Vivo Bioequivalence

Bioequivalence studies are crucial in evaluating whether new drugs can match an approved one regarding pharmacological effects and clinical performance. These studies test if drugs, despite different dosage forms, share identical plasma concentration-time profiles. Three types of equivalence are central to these studies: chemical, pharmaceutical, and therapeutic. Chemical equivalence indicates that two or more drug products contain identical active ingredients in equal amounts. Pharmaceutical...
Drug Product Performance: In Vitro–In Vivo Correlation01:20

Drug Product Performance: In Vitro–In Vivo Correlation

In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while adhering...

Articles linked to this work by shared authors, journal, and citation graph.

Identifying molecular signatures underpinning treatment responses to novel therapeutics influencing COVID-19 outcomes.

Journal of immunology (Baltimore, Md. : 1950)·2026

Erdosteine Provides Effective Analgesia in Inflammatory Pain Without Impairing Pain Resolution: A Preclinical Comparison With Non-Steroidal Anti-Inflammatory Drugs.

European journal of pain (London, England)·2026

The discovery and development of ensifentrine: A novel inhaled dual PDE3/4 inhibitor having 'bifunctional' bronchodilator and anti-inflammatory activity.

British journal of pharmacology·2026

Human iPSC-derived platelets generated in alginate scaffolds exhibit functional haemostasis in vitro and in vivo.

Thrombosis research·2026

Redox signaling in chronic airway diseases: pathogenic mechanisms and therapeutic implications.

Frontiers in physiology·2026

Pharmacological interactions between asthma and T2DM therapies: clinical and metabolic implications.

Expert opinion on drug metabolism & toxicology·2026

Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study.

Lancet (London, England)·2026

Robotic-arm-assisted versus conventional total knee replacement (RACER-Knee): a pragmatic, multicentre, participant-masked and assessor-masked, superiority, randomised controlled trial.

Lancet (London, England)·2026

Risk of transmission of amyloid β pathology via transfused blood products.

Lancet (London, England)·2026

Liver resection after atezolizumab and bevacizumab versus maintenance therapy for locally advanced hepatocellular carcinoma (TALENTOP): a multicentre, open-label, randomised, phase 3 trial.

Lancet (London, England)·2026

Zonisamide Improves Cognitive Impairment and Psychiatric Symptoms related with SAPAP3 in Mouse Models of Alzheimer's Disease.

European journal of pharmacology·2026

Enzyme-free dual-hotspot SERS immunosensor via cascaded boronate assembly.

Biosensors & bioelectronics·2026

Tuberculosis biomarker detection using the intrinsic photoluminescence of carbonated hydroxyapatite nanoparticles.

Talanta·2026

Next-Generation Sequencing Clonality Assays: Clinical Validation for Minimal Residual Disease Monitoring in Multiple Myeloma.

Journal of visualized experiments : JoVE·2026

Optimizing Sequential Decision Rules for Prostate Cancer Biopsy Management: A Multi-Objective Statistical Framework.

Journal of the American Statistical Association·2026

Time-Resolved Electrochemical Surface-Enhanced Resonance Raman Spectroscopy Double-Fingerprint for the Detection of Pseudomonas aeruginosa.

ACS measurement science au·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us